News
Richard J. Nowak, MD, MS, Yale School of Medicine, explains what some early myasthenia gravis symptoms are and their impact on research efforts.
Dr Nicholas Silvestri reports that the 2025 AAN meeting highlighted significant advances in myasthenia gravis, including ...
Watchers of the percolating myasthenia gravis space are waiting eagerly for data from Dianthus Therapeutics Inc.’s phase II Magic study testing DNTH-103, an active C1s inhibitor, compared to placebo ...
Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to ...
With myasthenia gravis, dysfunctional muscle and nerve communication ... Before prescribing Ultomiris, your doctor may order a blood test to check if your gMG is AChR antibody positive.
1mon
Medpage Today on MSNMyasthenia Gravis Antibody TypesMyasthenia gravis (MG) results from autoimmune antibodies ... "I recommend always having neurophysiological testing and not ...
As a result, the muscles become weak when a person performs repeated physical movements. The disease is neither contagious nor inherited but it is often misunderstood as a psychological issue or ...
Fast Five Quiz: Myasthenia Gravis Overview Myasthenia gravis is a relatively rare autoimmune disorder that can result in weakness that leads to neuromuscular respiratory failure. Test yourself on ...
SAN DIEGO -- Inebilizumab (Uplizna) improved function and reduced disease severity for up to 52 weeks in generalized myasthenia gravis (gMG) patients who were acetylcholine receptor (AChR ...
Interim results from the ME&MGopen study demonstrate strong adherence, high usability, and meaningful clinical associations in myasthenia ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results